nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0682	0.0857	CbGbCtD
Salmeterol—CYP3A7—Tamoxifen—pancreatic cancer	0.0682	0.0857	CbGbCtD
Salmeterol—CYP3A7—Irinotecan—pancreatic cancer	0.0523	0.0658	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0523	0.0658	CbGbCtD
Salmeterol—CYP3A5—Tamoxifen—pancreatic cancer	0.0511	0.0643	CbGbCtD
Salmeterol—CYP2C8—Tamoxifen—pancreatic cancer	0.0492	0.0618	CbGbCtD
Salmeterol—CYP3A5—Erlotinib—pancreatic cancer	0.0435	0.0547	CbGbCtD
Salmeterol—CYP2C8—Erlotinib—pancreatic cancer	0.0418	0.0526	CbGbCtD
Salmeterol—CYP3A5—Irinotecan—pancreatic cancer	0.0393	0.0494	CbGbCtD
Salmeterol—CYP3A7—Docetaxel—pancreatic cancer	0.0384	0.0482	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0384	0.0482	CbGbCtD
Salmeterol—CYP3A7—Sunitinib—pancreatic cancer	0.0382	0.048	CbGbCtD
Salmeterol—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0382	0.048	CbGbCtD
Salmeterol—CYP2C8—Fluorouracil—pancreatic cancer	0.0362	0.0455	CbGbCtD
Salmeterol—CYP3A5—Docetaxel—pancreatic cancer	0.0288	0.0362	CbGbCtD
Salmeterol—CYP3A5—Sunitinib—pancreatic cancer	0.0286	0.036	CbGbCtD
Salmeterol—CYP3A4—Tamoxifen—pancreatic cancer	0.0199	0.0251	CbGbCtD
Salmeterol—CYP3A4—Erlotinib—pancreatic cancer	0.017	0.0213	CbGbCtD
Salmeterol—CYP3A4—Irinotecan—pancreatic cancer	0.0153	0.0192	CbGbCtD
Salmeterol—CYP3A4—Docetaxel—pancreatic cancer	0.0112	0.0141	CbGbCtD
Salmeterol—CYP3A4—Sunitinib—pancreatic cancer	0.0112	0.014	CbGbCtD
Salmeterol—CYP3A4—Doxorubicin—pancreatic cancer	0.00836	0.0105	CbGbCtD
Salmeterol—Paraesthesia—Irinotecan—pancreatic cancer	0.000256	0.00125	CcSEcCtD
Salmeterol—Hypersensitivity—Sunitinib—pancreatic cancer	0.000255	0.00125	CcSEcCtD
Salmeterol—Rash—Tamoxifen—pancreatic cancer	0.000255	0.00125	CcSEcCtD
Salmeterol—Dermatitis—Tamoxifen—pancreatic cancer	0.000255	0.00124	CcSEcCtD
Salmeterol—Vomiting—Erlotinib—pancreatic cancer	0.000254	0.00124	CcSEcCtD
Salmeterol—Dyspnoea—Irinotecan—pancreatic cancer	0.000254	0.00124	CcSEcCtD
Salmeterol—Headache—Tamoxifen—pancreatic cancer	0.000253	0.00124	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000253	0.00124	CcSEcCtD
Salmeterol—Rash—Erlotinib—pancreatic cancer	0.000252	0.00123	CcSEcCtD
Salmeterol—Dermatitis—Erlotinib—pancreatic cancer	0.000252	0.00123	CcSEcCtD
Salmeterol—Insomnia—Gemcitabine—pancreatic cancer	0.000251	0.00123	CcSEcCtD
Salmeterol—Dyspepsia—Irinotecan—pancreatic cancer	0.000251	0.00123	CcSEcCtD
Salmeterol—Immune system disorder—Docetaxel—pancreatic cancer	0.000251	0.00123	CcSEcCtD
Salmeterol—Headache—Erlotinib—pancreatic cancer	0.000251	0.00122	CcSEcCtD
Salmeterol—Pain in extremity—Doxorubicin—pancreatic cancer	0.00025	0.00122	CcSEcCtD
Salmeterol—Mediastinal disorder—Docetaxel—pancreatic cancer	0.00025	0.00122	CcSEcCtD
Salmeterol—Paraesthesia—Gemcitabine—pancreatic cancer	0.00025	0.00122	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000249	0.00122	CcSEcCtD
Salmeterol—Asthenia—Sunitinib—pancreatic cancer	0.000249	0.00121	CcSEcCtD
Salmeterol—Arrhythmia—Docetaxel—pancreatic cancer	0.000248	0.00121	CcSEcCtD
Salmeterol—Dyspnoea—Gemcitabine—pancreatic cancer	0.000248	0.00121	CcSEcCtD
Salmeterol—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000247	0.00121	CcSEcCtD
Salmeterol—Insomnia—Fluorouracil—pancreatic cancer	0.000247	0.00121	CcSEcCtD
Salmeterol—Migraine—Doxorubicin—pancreatic cancer	0.000247	0.0012	CcSEcCtD
Salmeterol—Fatigue—Irinotecan—pancreatic cancer	0.000246	0.0012	CcSEcCtD
Salmeterol—Paraesthesia—Fluorouracil—pancreatic cancer	0.000245	0.0012	CcSEcCtD
Salmeterol—Constipation—Irinotecan—pancreatic cancer	0.000244	0.00119	CcSEcCtD
Salmeterol—Pain—Irinotecan—pancreatic cancer	0.000244	0.00119	CcSEcCtD
Salmeterol—Dyspnoea—Fluorouracil—pancreatic cancer	0.000244	0.00119	CcSEcCtD
Salmeterol—Mental disorder—Docetaxel—pancreatic cancer	0.000243	0.00119	CcSEcCtD
Salmeterol—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000242	0.00118	CcSEcCtD
Salmeterol—Malnutrition—Docetaxel—pancreatic cancer	0.000242	0.00118	CcSEcCtD
Salmeterol—Dyspepsia—Fluorouracil—pancreatic cancer	0.000241	0.00118	CcSEcCtD
Salmeterol—Nausea—Tamoxifen—pancreatic cancer	0.00024	0.00117	CcSEcCtD
Salmeterol—Fatigue—Gemcitabine—pancreatic cancer	0.00024	0.00117	CcSEcCtD
Salmeterol—Constipation—Gemcitabine—pancreatic cancer	0.000238	0.00116	CcSEcCtD
Salmeterol—Pain—Gemcitabine—pancreatic cancer	0.000238	0.00116	CcSEcCtD
Salmeterol—Nausea—Erlotinib—pancreatic cancer	0.000238	0.00116	CcSEcCtD
Salmeterol—Diarrhoea—Sunitinib—pancreatic cancer	0.000237	0.00116	CcSEcCtD
Salmeterol—Feeling abnormal—Irinotecan—pancreatic cancer	0.000235	0.00115	CcSEcCtD
Salmeterol—Asthma—Epirubicin—pancreatic cancer	0.000234	0.00114	CcSEcCtD
Salmeterol—Influenza—Epirubicin—pancreatic cancer	0.000234	0.00114	CcSEcCtD
Salmeterol—Back pain—Docetaxel—pancreatic cancer	0.000234	0.00114	CcSEcCtD
Salmeterol—Pain—Fluorouracil—pancreatic cancer	0.000234	0.00114	CcSEcCtD
Salmeterol—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000233	0.00114	CcSEcCtD
Salmeterol—Muscle spasms—Docetaxel—pancreatic cancer	0.000232	0.00114	CcSEcCtD
Salmeterol—Dizziness—Sunitinib—pancreatic cancer	0.000229	0.00112	CcSEcCtD
Salmeterol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000229	0.00112	CcSEcCtD
Salmeterol—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000229	0.00112	CcSEcCtD
Salmeterol—Abdominal pain—Irinotecan—pancreatic cancer	0.000226	0.0011	CcSEcCtD
Salmeterol—Body temperature increased—Irinotecan—pancreatic cancer	0.000226	0.0011	CcSEcCtD
Salmeterol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000225	0.0011	CcSEcCtD
Salmeterol—Bronchitis—Epirubicin—pancreatic cancer	0.000225	0.0011	CcSEcCtD
Salmeterol—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000224	0.00109	CcSEcCtD
Salmeterol—Vomiting—Sunitinib—pancreatic cancer	0.00022	0.00108	CcSEcCtD
Salmeterol—Body temperature increased—Gemcitabine—pancreatic cancer	0.00022	0.00107	CcSEcCtD
Salmeterol—Rash—Sunitinib—pancreatic cancer	0.000218	0.00107	CcSEcCtD
Salmeterol—Dermatitis—Sunitinib—pancreatic cancer	0.000218	0.00107	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000217	0.00106	CcSEcCtD
Salmeterol—Urticaria—Fluorouracil—pancreatic cancer	0.000217	0.00106	CcSEcCtD
Salmeterol—Headache—Sunitinib—pancreatic cancer	0.000217	0.00106	CcSEcCtD
Salmeterol—Asthma—Doxorubicin—pancreatic cancer	0.000216	0.00106	CcSEcCtD
Salmeterol—Influenza—Doxorubicin—pancreatic cancer	0.000216	0.00106	CcSEcCtD
Salmeterol—Body temperature increased—Fluorouracil—pancreatic cancer	0.000216	0.00106	CcSEcCtD
Salmeterol—Palpitations—Docetaxel—pancreatic cancer	0.000214	0.00104	CcSEcCtD
Salmeterol—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000211	0.00103	CcSEcCtD
Salmeterol—Cough—Docetaxel—pancreatic cancer	0.000211	0.00103	CcSEcCtD
Salmeterol—Hypersensitivity—Irinotecan—pancreatic cancer	0.00021	0.00103	CcSEcCtD
Salmeterol—Pneumonia—Epirubicin—pancreatic cancer	0.00021	0.00103	CcSEcCtD
Salmeterol—Hypertension—Docetaxel—pancreatic cancer	0.000209	0.00102	CcSEcCtD
Salmeterol—Infestation NOS—Epirubicin—pancreatic cancer	0.000209	0.00102	CcSEcCtD
Salmeterol—Infestation—Epirubicin—pancreatic cancer	0.000209	0.00102	CcSEcCtD
Salmeterol—Bronchitis—Doxorubicin—pancreatic cancer	0.000208	0.00102	CcSEcCtD
Salmeterol—Myalgia—Docetaxel—pancreatic cancer	0.000206	0.00101	CcSEcCtD
Salmeterol—Chest pain—Docetaxel—pancreatic cancer	0.000206	0.00101	CcSEcCtD
Salmeterol—Arthralgia—Docetaxel—pancreatic cancer	0.000206	0.00101	CcSEcCtD
Salmeterol—Nausea—Sunitinib—pancreatic cancer	0.000206	0.00101	CcSEcCtD
Salmeterol—Asthenia—Irinotecan—pancreatic cancer	0.000205	0.001	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000204	0.000998	CcSEcCtD
Salmeterol—Urinary tract infection—Epirubicin—pancreatic cancer	0.000203	0.000991	CcSEcCtD
Salmeterol—Conjunctivitis—Epirubicin—pancreatic cancer	0.000203	0.000991	CcSEcCtD
Salmeterol—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000201	0.000984	CcSEcCtD
Salmeterol—Dry mouth—Docetaxel—pancreatic cancer	0.000201	0.000983	CcSEcCtD
Salmeterol—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000201	0.000983	CcSEcCtD
Salmeterol—Asthenia—Gemcitabine—pancreatic cancer	0.000199	0.000974	CcSEcCtD
Salmeterol—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000197	0.000964	CcSEcCtD
Salmeterol—Oedema—Docetaxel—pancreatic cancer	0.000197	0.000964	CcSEcCtD
Salmeterol—Epistaxis—Epirubicin—pancreatic cancer	0.000197	0.000961	CcSEcCtD
Salmeterol—Infection—Docetaxel—pancreatic cancer	0.000196	0.000957	CcSEcCtD
Salmeterol—Sinusitis—Epirubicin—pancreatic cancer	0.000196	0.000956	CcSEcCtD
Salmeterol—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000195	0.000954	CcSEcCtD
Salmeterol—Diarrhoea—Irinotecan—pancreatic cancer	0.000195	0.000954	CcSEcCtD
Salmeterol—Pneumonia—Doxorubicin—pancreatic cancer	0.000194	0.000949	CcSEcCtD
Salmeterol—Nervous system disorder—Docetaxel—pancreatic cancer	0.000193	0.000945	CcSEcCtD
Salmeterol—Infestation—Doxorubicin—pancreatic cancer	0.000193	0.000943	CcSEcCtD
Salmeterol—Infestation NOS—Doxorubicin—pancreatic cancer	0.000193	0.000943	CcSEcCtD
Salmeterol—Tachycardia—Docetaxel—pancreatic cancer	0.000193	0.000941	CcSEcCtD
Salmeterol—Skin disorder—Docetaxel—pancreatic cancer	0.000192	0.000936	CcSEcCtD
Salmeterol—Diarrhoea—Gemcitabine—pancreatic cancer	0.00019	0.000929	CcSEcCtD
Salmeterol—Dizziness—Irinotecan—pancreatic cancer	0.000189	0.000922	CcSEcCtD
Salmeterol—Rhinitis—Epirubicin—pancreatic cancer	0.000188	0.000917	CcSEcCtD
Salmeterol—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000188	0.000917	CcSEcCtD
Salmeterol—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000188	0.000917	CcSEcCtD
Salmeterol—Diarrhoea—Fluorouracil—pancreatic cancer	0.000187	0.000914	CcSEcCtD
Salmeterol—Pharyngitis—Epirubicin—pancreatic cancer	0.000186	0.000908	CcSEcCtD
Salmeterol—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000184	0.000899	CcSEcCtD
Salmeterol—Epistaxis—Doxorubicin—pancreatic cancer	0.000182	0.00089	CcSEcCtD
Salmeterol—Vomiting—Irinotecan—pancreatic cancer	0.000181	0.000886	CcSEcCtD
Salmeterol—Sinusitis—Doxorubicin—pancreatic cancer	0.000181	0.000885	CcSEcCtD
Salmeterol—Dizziness—Fluorouracil—pancreatic cancer	0.000181	0.000883	CcSEcCtD
Salmeterol—Rash—Irinotecan—pancreatic cancer	0.00018	0.000879	CcSEcCtD
Salmeterol—Dermatitis—Irinotecan—pancreatic cancer	0.00018	0.000878	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00018	0.000878	CcSEcCtD
Salmeterol—Headache—Irinotecan—pancreatic cancer	0.000179	0.000873	CcSEcCtD
Salmeterol—Insomnia—Docetaxel—pancreatic cancer	0.000178	0.000872	CcSEcCtD
Salmeterol—Paraesthesia—Docetaxel—pancreatic cancer	0.000177	0.000865	CcSEcCtD
Salmeterol—Vomiting—Gemcitabine—pancreatic cancer	0.000177	0.000864	CcSEcCtD
Salmeterol—Dyspnoea—Docetaxel—pancreatic cancer	0.000176	0.000859	CcSEcCtD
Salmeterol—Rash—Gemcitabine—pancreatic cancer	0.000175	0.000856	CcSEcCtD
Salmeterol—Dermatitis—Gemcitabine—pancreatic cancer	0.000175	0.000856	CcSEcCtD
Salmeterol—Headache—Gemcitabine—pancreatic cancer	0.000174	0.000851	CcSEcCtD
Salmeterol—Cardiac disorder—Epirubicin—pancreatic cancer	0.000174	0.000849	CcSEcCtD
Salmeterol—Vomiting—Fluorouracil—pancreatic cancer	0.000174	0.000849	CcSEcCtD
Salmeterol—Rhinitis—Doxorubicin—pancreatic cancer	0.000174	0.000849	CcSEcCtD
Salmeterol—Dyspepsia—Docetaxel—pancreatic cancer	0.000174	0.000848	CcSEcCtD
Salmeterol—Rash—Fluorouracil—pancreatic cancer	0.000172	0.000842	CcSEcCtD
Salmeterol—Dermatitis—Fluorouracil—pancreatic cancer	0.000172	0.000841	CcSEcCtD
Salmeterol—Pharyngitis—Doxorubicin—pancreatic cancer	0.000172	0.00084	CcSEcCtD
Salmeterol—Headache—Fluorouracil—pancreatic cancer	0.000171	0.000837	CcSEcCtD
Salmeterol—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00017	0.000832	CcSEcCtD
Salmeterol—Fatigue—Docetaxel—pancreatic cancer	0.00017	0.000831	CcSEcCtD
Salmeterol—Nausea—Irinotecan—pancreatic cancer	0.000169	0.000828	CcSEcCtD
Salmeterol—Immune system disorder—Epirubicin—pancreatic cancer	0.000169	0.000826	CcSEcCtD
Salmeterol—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000169	0.000825	CcSEcCtD
Salmeterol—Pain—Docetaxel—pancreatic cancer	0.000169	0.000824	CcSEcCtD
Salmeterol—Constipation—Docetaxel—pancreatic cancer	0.000169	0.000824	CcSEcCtD
Salmeterol—Arrhythmia—Epirubicin—pancreatic cancer	0.000167	0.000817	CcSEcCtD
Salmeterol—Nausea—Gemcitabine—pancreatic cancer	0.000165	0.000807	CcSEcCtD
Salmeterol—Mental disorder—Epirubicin—pancreatic cancer	0.000164	0.000802	CcSEcCtD
Salmeterol—Malnutrition—Epirubicin—pancreatic cancer	0.000163	0.000797	CcSEcCtD
Salmeterol—Feeling abnormal—Docetaxel—pancreatic cancer	0.000163	0.000794	CcSEcCtD
Salmeterol—Nausea—Fluorouracil—pancreatic cancer	0.000162	0.000793	CcSEcCtD
Salmeterol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000161	0.000788	CcSEcCtD
Salmeterol—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000161	0.000786	CcSEcCtD
Salmeterol—Tension—Epirubicin—pancreatic cancer	0.00016	0.000782	CcSEcCtD
Salmeterol—Nervousness—Epirubicin—pancreatic cancer	0.000158	0.000774	CcSEcCtD
Salmeterol—Back pain—Epirubicin—pancreatic cancer	0.000158	0.00077	CcSEcCtD
Salmeterol—Muscle spasms—Epirubicin—pancreatic cancer	0.000157	0.000766	CcSEcCtD
Salmeterol—Immune system disorder—Doxorubicin—pancreatic cancer	0.000157	0.000765	CcSEcCtD
Salmeterol—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000156	0.000763	CcSEcCtD
Salmeterol—Abdominal pain—Docetaxel—pancreatic cancer	0.000156	0.000762	CcSEcCtD
Salmeterol—Body temperature increased—Docetaxel—pancreatic cancer	0.000156	0.000762	CcSEcCtD
Salmeterol—Arrhythmia—Doxorubicin—pancreatic cancer	0.000155	0.000756	CcSEcCtD
Salmeterol—Mental disorder—Doxorubicin—pancreatic cancer	0.000152	0.000742	CcSEcCtD
Salmeterol—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000151	0.000739	CcSEcCtD
Salmeterol—Malnutrition—Doxorubicin—pancreatic cancer	0.000151	0.000737	CcSEcCtD
Salmeterol—Agitation—Epirubicin—pancreatic cancer	0.00015	0.000732	CcSEcCtD
Salmeterol—Tension—Doxorubicin—pancreatic cancer	0.000148	0.000723	CcSEcCtD
Salmeterol—Malaise—Epirubicin—pancreatic cancer	0.000147	0.000718	CcSEcCtD
Salmeterol—Nervousness—Doxorubicin—pancreatic cancer	0.000147	0.000716	CcSEcCtD
Salmeterol—Back pain—Doxorubicin—pancreatic cancer	0.000146	0.000713	CcSEcCtD
Salmeterol—Hypersensitivity—Docetaxel—pancreatic cancer	0.000145	0.00071	CcSEcCtD
Salmeterol—Muscle spasms—Doxorubicin—pancreatic cancer	0.000145	0.000709	CcSEcCtD
Salmeterol—Palpitations—Epirubicin—pancreatic cancer	0.000144	0.000704	CcSEcCtD
Salmeterol—Cough—Epirubicin—pancreatic cancer	0.000142	0.000695	CcSEcCtD
Salmeterol—Asthenia—Docetaxel—pancreatic cancer	0.000142	0.000691	CcSEcCtD
Salmeterol—Hypertension—Epirubicin—pancreatic cancer	0.000141	0.000688	CcSEcCtD
Salmeterol—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00014	0.000684	CcSEcCtD
Salmeterol—Arthralgia—Epirubicin—pancreatic cancer	0.000139	0.000678	CcSEcCtD
Salmeterol—Chest pain—Epirubicin—pancreatic cancer	0.000139	0.000678	CcSEcCtD
Salmeterol—Myalgia—Epirubicin—pancreatic cancer	0.000139	0.000678	CcSEcCtD
Salmeterol—Agitation—Doxorubicin—pancreatic cancer	0.000139	0.000677	CcSEcCtD
Salmeterol—Anxiety—Epirubicin—pancreatic cancer	0.000138	0.000676	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000138	0.000673	CcSEcCtD
Salmeterol—Discomfort—Epirubicin—pancreatic cancer	0.000137	0.00067	CcSEcCtD
Salmeterol—Malaise—Doxorubicin—pancreatic cancer	0.000136	0.000665	CcSEcCtD
Salmeterol—Dry mouth—Epirubicin—pancreatic cancer	0.000136	0.000663	CcSEcCtD
Salmeterol—Diarrhoea—Docetaxel—pancreatic cancer	0.000135	0.000659	CcSEcCtD
Salmeterol—Palpitations—Doxorubicin—pancreatic cancer	0.000133	0.000651	CcSEcCtD
Salmeterol—Oedema—Epirubicin—pancreatic cancer	0.000133	0.00065	CcSEcCtD
Salmeterol—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000133	0.00065	CcSEcCtD
Salmeterol—Infection—Epirubicin—pancreatic cancer	0.000132	0.000646	CcSEcCtD
Salmeterol—Cough—Doxorubicin—pancreatic cancer	0.000132	0.000643	CcSEcCtD
Salmeterol—Nervous system disorder—Epirubicin—pancreatic cancer	0.00013	0.000638	CcSEcCtD
Salmeterol—Dizziness—Docetaxel—pancreatic cancer	0.00013	0.000637	CcSEcCtD
Salmeterol—Hypertension—Doxorubicin—pancreatic cancer	0.00013	0.000636	CcSEcCtD
Salmeterol—Tachycardia—Epirubicin—pancreatic cancer	0.00013	0.000634	CcSEcCtD
Salmeterol—Skin disorder—Epirubicin—pancreatic cancer	0.000129	0.000631	CcSEcCtD
Salmeterol—Myalgia—Doxorubicin—pancreatic cancer	0.000128	0.000627	CcSEcCtD
Salmeterol—Arthralgia—Doxorubicin—pancreatic cancer	0.000128	0.000627	CcSEcCtD
Salmeterol—Chest pain—Doxorubicin—pancreatic cancer	0.000128	0.000627	CcSEcCtD
Salmeterol—Anxiety—Doxorubicin—pancreatic cancer	0.000128	0.000625	CcSEcCtD
Salmeterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000128	0.000623	CcSEcCtD
Salmeterol—Discomfort—Doxorubicin—pancreatic cancer	0.000127	0.00062	CcSEcCtD
Salmeterol—Dry mouth—Doxorubicin—pancreatic cancer	0.000126	0.000614	CcSEcCtD
Salmeterol—Vomiting—Docetaxel—pancreatic cancer	0.000125	0.000613	CcSEcCtD
Salmeterol—Rash—Docetaxel—pancreatic cancer	0.000124	0.000608	CcSEcCtD
Salmeterol—Dermatitis—Docetaxel—pancreatic cancer	0.000124	0.000607	CcSEcCtD
Salmeterol—Headache—Docetaxel—pancreatic cancer	0.000124	0.000604	CcSEcCtD
Salmeterol—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000123	0.000601	CcSEcCtD
Salmeterol—Oedema—Doxorubicin—pancreatic cancer	0.000123	0.000601	CcSEcCtD
Salmeterol—Infection—Doxorubicin—pancreatic cancer	0.000122	0.000598	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000121	0.000592	CcSEcCtD
Salmeterol—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000121	0.00059	CcSEcCtD
Salmeterol—Insomnia—Epirubicin—pancreatic cancer	0.00012	0.000588	CcSEcCtD
Salmeterol—Tachycardia—Doxorubicin—pancreatic cancer	0.00012	0.000587	CcSEcCtD
Salmeterol—Skin disorder—Doxorubicin—pancreatic cancer	0.00012	0.000584	CcSEcCtD
Salmeterol—Paraesthesia—Epirubicin—pancreatic cancer	0.000119	0.000584	CcSEcCtD
Salmeterol—Dyspnoea—Epirubicin—pancreatic cancer	0.000119	0.00058	CcSEcCtD
Salmeterol—Nausea—Docetaxel—pancreatic cancer	0.000117	0.000572	CcSEcCtD
Salmeterol—Dyspepsia—Epirubicin—pancreatic cancer	0.000117	0.000572	CcSEcCtD
Salmeterol—Fatigue—Epirubicin—pancreatic cancer	0.000115	0.00056	CcSEcCtD
Salmeterol—Constipation—Epirubicin—pancreatic cancer	0.000114	0.000556	CcSEcCtD
Salmeterol—Pain—Epirubicin—pancreatic cancer	0.000114	0.000556	CcSEcCtD
Salmeterol—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000112	0.000548	CcSEcCtD
Salmeterol—Insomnia—Doxorubicin—pancreatic cancer	0.000111	0.000544	CcSEcCtD
Salmeterol—Paraesthesia—Doxorubicin—pancreatic cancer	0.000111	0.00054	CcSEcCtD
Salmeterol—Dyspnoea—Doxorubicin—pancreatic cancer	0.00011	0.000536	CcSEcCtD
Salmeterol—Feeling abnormal—Epirubicin—pancreatic cancer	0.00011	0.000536	CcSEcCtD
Salmeterol—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000109	0.000532	CcSEcCtD
Salmeterol—Dyspepsia—Doxorubicin—pancreatic cancer	0.000108	0.000529	CcSEcCtD
Salmeterol—Fatigue—Doxorubicin—pancreatic cancer	0.000106	0.000519	CcSEcCtD
Salmeterol—Urticaria—Epirubicin—pancreatic cancer	0.000106	0.000516	CcSEcCtD
Salmeterol—Pain—Doxorubicin—pancreatic cancer	0.000105	0.000514	CcSEcCtD
Salmeterol—Constipation—Doxorubicin—pancreatic cancer	0.000105	0.000514	CcSEcCtD
Salmeterol—Body temperature increased—Epirubicin—pancreatic cancer	0.000105	0.000514	CcSEcCtD
Salmeterol—Abdominal pain—Epirubicin—pancreatic cancer	0.000105	0.000514	CcSEcCtD
Salmeterol—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000101	0.000496	CcSEcCtD
Salmeterol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000101	0.000492	CcSEcCtD
Salmeterol—Hypersensitivity—Epirubicin—pancreatic cancer	9.8e-05	0.000479	CcSEcCtD
Salmeterol—Urticaria—Doxorubicin—pancreatic cancer	9.78e-05	0.000478	CcSEcCtD
Salmeterol—Abdominal pain—Doxorubicin—pancreatic cancer	9.73e-05	0.000475	CcSEcCtD
Salmeterol—Body temperature increased—Doxorubicin—pancreatic cancer	9.73e-05	0.000475	CcSEcCtD
Salmeterol—Asthenia—Epirubicin—pancreatic cancer	9.55e-05	0.000466	CcSEcCtD
Salmeterol—Diarrhoea—Epirubicin—pancreatic cancer	9.1e-05	0.000445	CcSEcCtD
Salmeterol—Hypersensitivity—Doxorubicin—pancreatic cancer	9.07e-05	0.000443	CcSEcCtD
Salmeterol—Asthenia—Doxorubicin—pancreatic cancer	8.83e-05	0.000432	CcSEcCtD
Salmeterol—Dizziness—Epirubicin—pancreatic cancer	8.8e-05	0.00043	CcSEcCtD
Salmeterol—Vomiting—Epirubicin—pancreatic cancer	8.46e-05	0.000413	CcSEcCtD
Salmeterol—Diarrhoea—Doxorubicin—pancreatic cancer	8.42e-05	0.000412	CcSEcCtD
Salmeterol—Rash—Epirubicin—pancreatic cancer	8.39e-05	0.00041	CcSEcCtD
Salmeterol—Dermatitis—Epirubicin—pancreatic cancer	8.38e-05	0.000409	CcSEcCtD
Salmeterol—Headache—Epirubicin—pancreatic cancer	8.34e-05	0.000407	CcSEcCtD
Salmeterol—Dizziness—Doxorubicin—pancreatic cancer	8.14e-05	0.000398	CcSEcCtD
Salmeterol—Nausea—Epirubicin—pancreatic cancer	7.9e-05	0.000386	CcSEcCtD
Salmeterol—Vomiting—Doxorubicin—pancreatic cancer	7.83e-05	0.000382	CcSEcCtD
Salmeterol—Rash—Doxorubicin—pancreatic cancer	7.76e-05	0.000379	CcSEcCtD
Salmeterol—Dermatitis—Doxorubicin—pancreatic cancer	7.75e-05	0.000379	CcSEcCtD
Salmeterol—Headache—Doxorubicin—pancreatic cancer	7.71e-05	0.000377	CcSEcCtD
Salmeterol—Nausea—Doxorubicin—pancreatic cancer	7.31e-05	0.000357	CcSEcCtD
